MRI criteria for dissemination in space in patients with clinically isolated syndromes:: a multicentre follow-up study

被引:98
作者
Korteweg, T
Tintoré, M
Uitdehoog, B
Rovira, A
Frederiksen, J
Miller, D
Fernando, K
Filippi, M
Agosta, F
Rocca, M
Fazekas, F
Enzinger, C
Matthews, P
Parry, A
Polman, C
Montalban, X
Barkhof, F
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Neuroradiol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands
[4] Hosp Valle De Hebron, Dept Neuroimmunol, Barcelona, Spain
[5] Hosp Valle De Hebron, Dept Radiol, Magnet Resonance Unit, Barcelona, Spain
[6] Univ Copenhagen, Glostrup Hosp, Dept Neurol, MS Clin, DK-1168 Copenhagen, Denmark
[7] UCL, Inst Neurol, Dept Neuroinflammat, MS NMR Res Unit, London, England
[8] Ist Sci San Raffaele, Dept Neurol, Neuroimaging Res Unit, I-20132 Milan, Italy
[9] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy
[10] Med Univ Graz, Dept Neurol, Graz, Austria
[11] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England
关键词
D O I
10.1016/S1474-4422(06)70353-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background The McDonald International Panel accepted the Barkhof/Tintore criteria for providing MRI evidence of dissemination in space to allow a diagnosis of multiple sclerosis in patients with clinically isolated syndromes (CIS). We applied these criteria in a large cohort of patients with CIS, representative of those seen in a general diagnostic setting, to assess their accuracy in predicting conversion to definite multiple sclerosis and to identify factors that affect this risk. Methods In a collaborative study of seven centres, baseline MRI and clinical follow-up data for 532 patients with CIS were studied, with the development of a second clinical event used as the main outcome. All scans were scored for lesion counts and spatial lesion distribution to assess the fulfilment-ie, at least three out of four-of the Barkhof/Tintore criteria. We used survival analysis and 2 X 2 tables to assess the test characteristics of the criteria at baseline. Findings Overall conversion rate was 32.5% with a median survival time of 85.3 months. Fulfilment of the criteria at baseline showed, after a survival time of 2 years, a conversion rate of about 45% (95% Cl 37-53) versus about 10% (6-16) in those with no asymptomatic lesions at baseline (p<0.0001). For patients with a follow-up of at least 2 years, the fulfilment of the MRI criteria showed an accuracy of 68% (sensitivity 49%, specificity 79%) for predicting conversion and an increase in risk of nearly four times for conversion compared with those not fulfilling the criteria (odds ratio 3.7, 95% CI 2.3-5.9; p<0.0001). Cox proportional hazards regression analysis accorded with this increased risk. No effects were recorded on the performance of the criteria by sex, presenting symptoms, or Centre. Age at baseline did have a small but significant effect as predictor (hazard ratio 0.97, 0.95-0.99; p=0.002), but did not affect the prognostic value of the MRI criteria. Interpretation MRI abnormalities have important prognostic value. The cut-off, based on the Barkhof/Tintore criteria, as incorporated in the McDonald diagnostic scheme yields acceptable specificity, but could have lower sensitivity than previously reported.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 16 条
[1]  
[Anonymous], 2002, Mult Scler, V8, P330
[2]   Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a [J].
Barkhof, F ;
Rocca, M ;
Francis, G ;
van Waesberghe, JHTM ;
Uitdehaag, BMJ ;
Hommes, OR ;
Hartung, HP ;
Durelli, L ;
Edan, G ;
Fernández, O ;
Seeldrayers, P ;
Sorensen, P ;
Margrie, S ;
Rovaris, M ;
Comi, G ;
Filippi, M .
ANNALS OF NEUROLOGY, 2003, 53 (06) :718-724
[3]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[4]   A longitudinal study of abnormalities on MRI and disability from multiple sclerosis [J].
Brex, PA ;
Ciccarelli, O ;
O'Riordan, JI ;
Sailer, M ;
Thompson, AJ ;
Miller, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) :158-164
[5]   Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis [J].
Dalton, CM ;
Brex, PA ;
Miszkiel, KA ;
Hickman, SJ ;
MacManus, DG ;
Plant, GT ;
Thompson, AJ ;
Miller, DH .
ANNALS OF NEUROLOGY, 2002, 52 (01) :47-53
[6]   The utility of MRI in suspected MS - Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology [J].
Frohman, EM ;
Goodin, DS ;
Calabresi, PA ;
Corboy, JR ;
Coyle, PK ;
Filippi, M ;
Frank, JA ;
Galetta, SL ;
Grossman, RI ;
Hawker, K ;
Kachuck, NJ ;
Levin, MC ;
Phillips, JT ;
Racke, MK ;
Rivera, VM ;
Stuart, WH .
NEUROLOGY, 2003, 61 (05) :602-611
[7]   Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis [J].
McDonald, WI ;
Compston, A ;
Edan, G ;
Goodkin, D ;
Hartung, HP ;
Lublin, FD ;
McFarland, HF ;
Paty, DW ;
Polman, CH ;
Reingold, SC ;
Sandberg-Wollheim, M ;
Sibley, W ;
Thompson, AJ ;
van den Noort, S ;
Weinshenker, BY ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2001, 50 (01) :121-127
[8]  
Moraal B, 2005, MULT SCLER, V11, pS149
[9]  
O'Connor P, 2002, NEUROLOGY, V59, P998
[10]   The effect of spectrum bias on the utility of magnetic resonance imaging and evoked potentials in the diagnosis of suspected multiple sclerosis [J].
OConnor, PW ;
Tansey, CM ;
Detsky, AS ;
Mushlin, AI ;
Kucharczyk, W .
NEUROLOGY, 1996, 47 (01) :140-144